Skip to main content
. Author manuscript; available in PMC: 2021 Oct 22.
Published in final edited form as: Circulation. 2017 Jan 30;135(9):e96–e121. doi: 10.1161/CIR.0000000000000476

Table 1.

Intermittent Fasting: Effect on CHD Risk Parameters

Reference Duration, wk Subjects Intervention Weight, % Change CHD Risk Parameters, % Change
TC LDL HDL TG SBP DBP Glucose Insulin HOMA-IR
Alternate-day fasting (fasting 3–4 d/wk)
 Heilbronn et al,80 2005 3 n=16, M and F
Age, 23–53 y
Overweight Race/ethnicity: NR
Fast day: 0% intake
Feed day: ad libitum intake
Food not provided
↓3* ↑VNR in women only* ↓VNR* ↓1 ↓57*
 Eshghinia and Mohammadzadeh,81 2013 6 n=15, F
Age, 34±6 y
Obese Race/ethnicity: NR
Fast day: 30% intake
Feed day: ad libitum intake
Food not provided
↓7* ↓6 ↓12 ↑19 ↓11 ↓8* ↓10* ↓6
 Johnson et al,82 2007 8 n=10, M and F
Age: NR
Obese Race/ethnicity: NR
Fast day: 20% intake
Feed day: ad libitum intake
Food provided on fast day
↓8* ↓9* ↓10 ↑4 ↓42* ↑6 ↓37* ↓33*
 Varady et al,83 2009 8 n=16, M and F
Age, 46±2 y
Obese Prediabetic Race/ethnicity:
6–H
8–B
2–W
Fast day: 25% intake
Feed day: ad libitum intake
Food provided on fast day
↓6* ↓21* ↓32* ↑9 ↓35* ↓6* ↓6* ↓4* ↓20* ↓19*
 Klempel et al,84 2012 8 n=32, F
Age, 42±2 y
Obese Race/ethnicity:
8–H
24–B
0–W
Fast day: 25% intake, high fat
Feed day: ad libitum intake, high fat
Fast day: 25% intake, low fat
Feed day: ad libitum intake, low fat
Food provided all days in all groups
↓5*
↓4*
↓13*
↓16*
↓18*
↓25*
↓1
↑5
↓14*
↓24*
↓2
↓2
↓3
↑3
↓2
↓2
 Hoddy et al,85 2014 8 n=74, M and F
Age, 45±3 y
Obese Race/ethnicity: NR
Fast day: 25% intake as lunch
Feed day: ad libitum intake
Fast day: 25% intake as dinner
Feed day: ad libitum intake
Fast day: 25% intake as small meals
Feed day: ad libitum intake
Food provided on fast day in all groups
↓4*
↓4*
↓4*
↓1
↓3
0
↓1
0
0
↓4
0
↓2
↓6
↓8
↓1
↓2
↓4
↓5*
↓1
↓4
↓1
↓2
↓1
↓1
0
↓18
↓12
↓10
↓26
↓19
 Bhutani et al,86 2013 12 n=32, M and F
Age, 43±3 y
Obese Race/ethnicity:
18–H
41–B
21–W
3–Other
Fast day: 25% intake
Feed day: ad libitum intake
Food provided on fast day
Control: ad libitum fed every day
Food not provided
↓4*
0
↑7
↑1
↓1
↑3
0
↑8
↑3
↑5
↓3*
↓2
↓2
↓2
↓3
↑2
↓11
↑1
↓9
↑2
 Varady et al,87 2013 12 n=32, M and F
Age, 47±4y
Normal weight and overweight Prediabetic Race/ethnicity:
3–H
13–B
14–W
Fast day: 25% intake
Feed day: ad libitum intake
Food provided on fast day Control: ad libitum fed every day
Food not provided
↓7*
↓1
↓13*
↓4
↓16*
↓7
↓4
↑2
↓2*
↑9
↓6*
↑1
↓6*
↑1
↓8*
↑2
↓31
↑2
↓28
↑2
Periodic fasting (fasting 1–2 d/wk)
 Klempel et al,88 2012 8 n=54, F
Age, 48±2 y Obese Prediabetic Race/ethnicity:
9–H
34–B
6–W
5–A
1 d/wk: 0% intake
6 d/wk: 70% intake, liquid diet
Food provided
1 d/wk: 0% intake
6 d/wk: 70% intake, food diet
Food not provided
↓4*
↓3*
↓19*
↓8*
↓20*
↓7*
↓5
↓2
↓17*
↓3
↓2
↓5
↓5
0
↓3*
↓2
↓21*
↓13
↓23*
↓12
 Harvie et al,89 2011 24 n=53,F
Age, 30–45 y
Overweight and obese Race/ethnicity:
2–B
103–W
2–Other
2 d/wk: 25% intake
5 d/wk: ad libitum intake
Food not provided
↓7* ↓6* ↓10* 0 ↓16* ↓3* ↓6* ↓2 ↓29* ↓27*

A indicates Asian; B, black, African American, or Afro-Caribbean; CHD, coronary heart disease; DBP, diastolic blood pressure; F, female; H, Hispanic; HDL, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment of insulin resistance; LDL, low-density lipoprotein cholesterol; M, male; NR, not reported; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; VNR, value not reported; and W, white.

*

Posttreatment value significantly different from baseline value (P<0.05).

Significantly different from control group (P<0.05).

Reflects 30 of 32 completing the study and included in the analyses.